Home / Inspections / 1312800

FDA Inspection 1312800 — LGM Pharma LLC

LGM Pharma LLC — FEI 3012048333

The FDA completed an inspection of LGM Pharma LLC on March 12, 2026 in Erlanger, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 12, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Erlanger, KY (United States)

Facility

Other inspections at this facility

  • 1242488 (VAI Fri Jun 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1166776 (OAI Fri Apr 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1073414 (OAI Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

  • Injunction (379) (Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources